These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34017447)

  • 1. High expression of SIX1 is an independent predictor of poor prognosis in endometrial cancer.
    Li W; Qin Y; Zhou R; Liu Y; Zhang G
    Am J Transl Res; 2021; 13(4):2840-2848. PubMed ID: 34017447
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Zhao Q; Chen G; Yang X; Wang T; Yuan S; Meng Q
    Comb Chem High Throughput Screen; 2023; 26(2):330-338. PubMed ID: 35379118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
    Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
    Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Six1 expression is associated with poor prognosis in patients with osteosarcoma.
    Chao L; Liu J; Zhao D
    Oncol Lett; 2017 May; 13(5):2891-2896. PubMed ID: 28521394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway.
    Huang S; Lin W; Wang L; Gao Y; Yuan X; Zhang P; Chen Y; Chu Q
    J Cancer; 2022; 13(2):527-540. PubMed ID: 35069900
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased expression of Six1 correlates with progression and prognosis of prostate cancer.
    Zeng J; Shi R; Cai CX; Liu XR; Song YB; Wei M; Ma WL
    Cancer Cell Int; 2015; 15():63. PubMed ID: 26161040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
    Wu H; Zhang J
    Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIX1 amplification modulates stemness and tumorigenesis in breast cancer.
    Guo L; Li F; Liu H; Kong D; Chen C; Sun S
    J Transl Med; 2023 Nov; 21(1):866. PubMed ID: 38031089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIX1 is overexpressed in endometrial carcinoma and promotes the malignant behavior of cancer cells through ERK and AKT signaling.
    Xin X; Li Y; Yang X
    Oncol Lett; 2016 Nov; 12(5):3435-3440. PubMed ID: 27900017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.
    Kahlert C; Lerbs T; Pecqueux M; Herpel E; Hoffmeister M; Jansen L; Brenner H; Chang-Claude J; Bläker H; Kloor M; Roth W; Pilarsky C; Rahbari NN; Schölch S; Bork U; Reissfelder C; Weitz J; Aust D; Koch M
    Int J Cancer; 2015 Nov; 137(9):2104-13. PubMed ID: 25951369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIX1 overexpression in diffuse-type and grade III gastric tumors: Features that are associated with poor prognosis.
    Emadi-Baygi M; Nikpour P; Emadi-Andani E
    Adv Biomed Res; 2015; 4():139. PubMed ID: 26322287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of Six1 and Six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis].
    Wei Q; Yu WW; Zhao KL; Fu XL; Zhu ZF; Qin GQ; Chen H; Zhang ZX; Gu YZ; Xiang JQ; Chen HQ; Du X; Sun MH
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):446-50. PubMed ID: 24246862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six1 expression is associated with a poor prognosis in patients with glioma.
    Zhang X; Xu R
    Oncol Lett; 2017 Mar; 13(3):1293-1298. PubMed ID: 28454249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Significance of SIX1 as a Prognostic Biomarker for Survival Outcome in Various Cancer Patients: A Systematic Review and Meta-Analysis.
    Zhu G; Liu Y; Zhao L; Lin Z; Piao Y
    Front Oncol; 2021; 11():622331. PubMed ID: 34745930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C; Zhang B; Li YL; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIX1 Regulates Aberrant Endometrial Epithelial Cell Differentiation and Cancer Latency Following Developmental Estrogenic Chemical Exposure.
    Suen AA; Jefferson WN; Wood CE; Williams CJ
    Mol Cancer Res; 2019 Dec; 17(12):2369-2382. PubMed ID: 31597742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-489-3p/SIX1 Axis Regulates Melanoma Proliferation and Glycolytic Potential.
    Yang X; Zhu X; Yan Z; Li C; Zhao H; Ma L; Zhang D; Liu J; Liu Z; Du N; Ye Q; Xu X
    Mol Ther Oncolytics; 2020 Mar; 16():30-40. PubMed ID: 32258386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.
    Du J
    Anticancer Drugs; 2019 Jul; 30(6):596-603. PubMed ID: 30672777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.